Fig. 1From: Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cellsCorrelations between plasma level of AGE-p and FMD in type 2 diabetic patients with or without coronary artery disease. AGE-p: advanced glycation end product peptides (U/ml); FMD: flow-mediated vasodilatation (%)Back to article page